Federal Register / Vol. 77, No. 38 / Monday, February 27, 2012 / Notices 11545 

assessed; the estimated burden for this 

as needed assessment is 375 hours. The 

costs of sponsored activities for 50 

community and clinical partners; the 

estimated burden for this yearly 

assessment is 125 hours. 

All information can be reported to 

CDC through an interactive web-based 

system, ‘‘iGTO,’’ that awardees can use 

to manage their general organizational 

information and to support and track 

the implementation of strategies to 

prevent teen pregnancy. Respondents 

who prefer not to use the iGTO system 

will be able to export the assessment 

tools, complete them, and return their 

reports to CDC by electronic mail. 

Assessment and performance 

information will be reported to CDC 

annually. In addition, CDC will collect 

information about costs and awardee 

needs for training and technical 

assistance. To ensure high data quality, 

cost information will be submitted as 

soon as it becomes available. CDC 

estimates that each state or community 

awardee will submit 10 cost data reports 

per year. Training and technical 

assistance needs will be reported 

monthly so that CDC can provide 

immediate, targeted technical assistance 

as needed. The assessment information, 

performance measures and training and 

technical assistance information to be 

collected are critical to understanding 

(1) the teen pregnancy prevention needs 

of each target community, (2) quality 

implementation practices associated 

with evidence-based programs and 

contraceptive access, and (3) the impact 

of implemented strategies. 

OMB approval is requested for three 

years. There are no costs to respondents 

other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(hr) 

Total burden 

(hr) 

State and Community Awardees ...... Project Director/Coordinator Needs 

Assessment.

9 1 45/60 7 

Performance Measure Assessment 

Tool.

50 1 4 200 

Staff Assessment ............................. 50 1 45/60 38 

Training and Technical Assistance 

Tool.

50 12 1 600 

Cost Reporting Form For Sponsored 

Activities.

50 10 15/60 125 

National Organization Awardees ...... Training and Technical Assistance 

Tool.

15 112 ........................ 180 

Community and Clinical Partners ..... Clinical Provider Needs Assessment 

Tool.

50 1 1 50 

Program Implementation Partner 

Needs Assessment Tool.

100 1 45/60 75 

Partner Cost Reporting Form for 

Participants.

150 10 15/60 375 

Cost Reporting Form For Sponsored 

Activities.

50 10 15/60 125 

Total ........................................... ........................................................... ........................ ........................ ........................ 1,775 

Kimberly S. Lane, 

Chief Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2012–4550 Filed 2–24–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–12–12EG] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–7570 or send 

comments to Kimberly Lane, CDC 

Reports Clearance Officer, 1600 Clifton 

Road, MS D–74, Atlanta, GA 30333 or 

send an email to omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Use of Smartphones to Collect 

Information about Health Behaviors: 

Feasibility Study—New—National 

Center for Chronic Disease Prevention 

and Health Promotion (NCCDPHP), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

Despite the high level of public 

knowledge about the adverse effects of 

smoking, tobacco use remains the 

leading preventable cause of disease and 

death in the U.S., resulting in 

approximately 443,000 deaths annually. 

During 2005–2010, the overall 

proportion of U.S. adults who were 

current smokers declined from 20.9% to 

19.3%. Despite this decrease, smoking 

rates are still well above Healthy People 

2010 targets for reducing adult smoking 


srobinson on DSK4SPTVN1PROD with NOTICES
11546 Federal Register / Vol. 77, No. 38 / Monday, February 27, 2012 / Notices 

prevalence to 12%, and the decline in 

prevalence was not uniform across the 

population. 

One of the highest priorities 

emanating from the American Recovery 

and Reinvestment Act of 2009 is tobacco 

control and cessation programs. In 

addition, the Family Smoking 

Prevention and Tobacco Control Act 

gave the Food and Drug Administration 

new authority to regulate tobacco 

products, and the Children’s Health 

Insurance Program Reauthorization Act 

of 2009 included increases in Federal 

excise taxes on tobacco products. These 

developments reinforce the importance 

of timely collection of data related to 

tobacco usage. 

The evolution of new 

communications technologies that are 

completely mobile provides a unique 

opportunity for innovation in public 

health. Text messaging and smartphone 

web access are immediate, accessible, 

and anonymous, a combination of 

features that could make smartphones 

ideal for the ongoing research, 

surveillance, and evaluation of risk 

behaviors and health conditions, as well 

as targeted dissemination of 

information. 

CDC proposes to conduct a feasibility 

study to identify and evaluate the 

process of conducting surveys by text 

message and smartphone, the outcomes 

of the surveys, and the value of the 

surveys. Before initiating the feasibility 

study, CDC will conduct a brief pre-test 

of information collection forms and 

procedures. The universe for this study 

is English-speaking U.S. residents aged 

18–65. The sample frame will consist of 

a national random digit dial sample of 

telephone numbers from a frame of 

known cell phone exchanges. 

Respondents will be recruited from this 

sample frame by calling cell phones 

numbers and asking respondents to 

complete an initial CATI survey 

consisting of a short series of simple 

demographic questions, general health 

questions, and questions about tobacco 

and alcohol use. At the conclusion of 

this brief survey, all respondents who 

have smartphones and a subset of 

respondents who do not have 

smartphones will be asked to participate 

in the follow-up portion of the 

feasibility study consisting of a first 

follow-up survey and, a week later, a 

second follow-up survey. Smartphone 

respondents who agree will receive 

invitations to participate by text 

message, which will include a link to 

the survey. Non-smartphone 

respondents who agree will receive a 

text message inviting them to 

participate; respondents opting in will 

be texted survey questions one at a time. 

This study will evaluate: (1) Response 

bias of a smartphone health survey by 

comparing data collected via CATI to 

data collected via smartphones/text 

messages, and data collected via 

smartphones to data collected via text 

messages, (2) relative cost-effectiveness 

of data collected via CATI to data 

collected via smartphones/text 

messages; (3) coverage bias associated 

with restricting the sample to 

smartphone users; and (4) the utility of 

smartphones for completing frequent, 

short interviews (i.e. diary studies to 

track activities or events). 

OMB approval is requested for one 

year. Participation is voluntary and 

respondents can choose not to 

participate at any time. There are no 

costs to respondents other than their 

time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hr) 

Total burden 

(in hr) 

Smartphone and non-smartphone users aged 18–65 ......... Pre-test of 

CATI 

Screener/Initial 

CATI Survey 

20 1 8/60 3 

CATI Screener 1,990 1 1/60 33 

Initial CATI 

Survey 

995 1 7/60 116 

Smartphone Users aged 18–65 ........................................... First Web 

Survey Followup for 

Smartphone 

Users 

697 1 3/60 35 

Second Web 

Survey Followup for 

Smartphone 

Users 

592 1 3/60 30 

Non-smartphone Users aged 18–65 ................................... First Text 

Message 

Survey Followup for nonSmartphone 

Users 

200 1 3/60 10 

Second Text 

Message 

Survey Followup for nonSmartphone 

Users 

170 1 3/60 9 

Total .............................................................................. ........................ ........................ ........................ ........................ 236 


srobinson on DSK4SPTVN1PROD with NOTICES
Federal Register / Vol. 77, No. 38 / Monday, February 27, 2012 / Notices 11547 

Kimberly Lane, 

Reports Clearance Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2012–4549 Filed 2–24–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention (CDC) 

Advisory Board on Radiation and 

Worker Health (ABRWH or Advisory 

Board), National Institute for 

Occupational Safety and Health 

(NIOSH) 

The meeting scheduled to convene on 

February 28–29, 2012 was published in 

the Federal Register on February 16, 

2012, Volume 77, Number 32, Pages 

9254–9255. This notice was put on 

display for 12 days in advance of the 

meeting instead of the 15 calendar days 

required in accordance with section 

10(a)(2) of the Federal Advisory 

Committee Act (Pub. L. 92–463), and 

pursuant to the requirements of 42 CFR 

83.15(a). 

CONTACT PERSON FOR MORE INFORMATION: 

Theodore Katz, M.P.A., Executive 

Secretary, NIOSH, CDC, 1600 Clifton 

Road, NE., MS E–20, Atlanta, Georgia 

30333, Telephone: (513) 533–6800, toll 

free: 1–800–CDC–INFO, email: 

dcas@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: February 17, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–4569 Filed 2–24–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2011–N–0320] 

Agency Information Collection 

Activities; Submission for Office of 

Management and Budget Review; 

Comment Request; Experimental 

Study on Consumer Responses to 

Whole Grain Labeling Statements on 

Food Packages 

AGENCY: Food and Drug Administration, 

HHS 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a proposed collection of 

information has been submitted to the 

Office of Management and Budget 

(OMB) for review and clearance under 

the Paperwork Reduction Act of 1995. 

DATES: Fax written comments on the 

collection of information by March 28, 

2012. 

ADDRESSES: To ensure that comments on 

the information collection are received, 

OMB recommends that written 

comments be faxed to the Office of 

Information and Regulatory Affairs, 

OMB, Attn: FDA Desk Officer, FAX: 

202–395–7285, or emailed to 

oira_submission@omb.eop.gov. All 

comments should be identified with the 

OMB control number 0910–New and 

title ‘‘Experimental Study on Consumer 

Responses to Whole Grain Labeling 

Statements on Food Packages.’’ Please 

also include the FDA docket number 

found in brackets in the heading of this 

document. 

FOR FURTHER INFORMATION CONTACT: 

Denver Presley, II, Office of Information 

Management, Food and Drug 

Administration, 1350 Piccard Dr., PI50– 

400B, Rockville, MD 20850, 301–796– 

3793. 

SUPPLEMENTARY INFORMATION: In 

compliance with 44 U.S.C. 3507, FDA 

has submitted the following proposed 

collection of information to OMB for 

review and clearance. 

Experimental Study on Consumer 

Responses to Whole Grain Labeling 

Statements on Food Packages—(OMB 

Control Number 0910–New) 

I. Background 

The Nutrition Labeling and Education 

Act, which amended the Federal Food, 

Drug, and Cosmetic Act, requires most 

foods to bear nutrition labeling (i.e., the 

Nutrition Facts) and requires food labels 

that bear nutrient content claims and 

certain health messages to comply with 

specific requirements. There are three 

different types of claims (health claims, 

nutrient content claims, and structure/ 

function claims) that the food industry 

can voluntarily use on food labels. 

Although they are regulated differently, 

they all must be truthful and not 

misleading (Ref. 1). 

In the past 30 years, whole-grain 

consumption has been greatly promoted 

by government agencies and scientific 

communities as an important part of a 

healthy diet (Refs. 2 and 3). For 

example, the newly released ‘‘Dietary 

Guidelines for Americans 2010’’ 

recommends Americans eat fewer 

refined grains and consume more 

nutrient-dense whole grains instead 

(Ref. 4). At the same time, whole grain 

labeling statements, such as ‘‘Made 

With Whole Grain’’, on food products 

have also become more prevalent in 

recent years (Ref. 5). Given the variety 

of whole-grain statements on food 

products and the importance of whole 

grains in maintaining a healthy diet, it 

is important for policy makers to gain a 

better understanding of how consumers 

interpret these statements. 

Several studies indicate that 

consumers may have difficulties in 

understanding the meaning of whole 

grains or recognizing whole-grain foods 

(Refs. 6 to 8). Research also suggests 

consumer product perceptions and 

purchase decisions can be influenced by 

labeling statements, and different 

labeling statements may have different 

influences (Refs. 9 and 10). The majority 

of existing studies focus on whole grain 

intake or the relationships between 

whole grain and disease prevention. 

There is a lack of systematic 

investigation of consumers’ 

understanding of different whole-grain 

labeling statements. We are aware of at 

least one existing study related to the 

statements (Ref. 11). However, the study 

did not compare consumer reactions to 

various whole-grain statements. 

Therefore, FDA, as part of its effort to 

promote public health, plans to use the 

proposed study to explore and compare 

consumer responses to food labels that 

use whole-grain labeling statements. 

Specifically, the study plans to 

examine: (1) Consumer judgments about 

a food product including its nutritional 

attributes, overall healthiness, and 

health benefits; (2) consumer judgments 

about a labeling statement in terms of its 

credibility, helpfulness, and other 

attributes; (3) consumer interpretations 

of different terms and statements, such 

as ‘‘Made with Whole Grain’’, ‘‘MultiGrain’’, and ‘‘100% Whole Wheat’’; (4) 

consumer extrapolation of whole grain 

statements beyond the scope of the 

statements themselves (i.e., halo effects); 


srobinson on DSK4SPTVN1PROD with NOTICES